D.C. Mun. Regs. tit. 22, r. 22-B125

Current through Register Vol. 71, No. 49, December 6, 2024

Rule 22-B125 - REPORTING OF CANCER AND OTHER MALIGNANT NEOPLASTIC DISEASES

125.1

The purpose of this section is to provide for the reporting of cases of cancer and other malignant neoplastic diseases to the Director.

125.2

This section shall be applicable to all cases of cancer, sarcoma, lymphoma (including Hodgkin's Disease), leukemia, and all other malignant neoplasms.

125.3

For the purposes of this section, unless otherwise provided, the following terms shall have the meaning ascribed:

(a) The term "Act" means the Act of Congress codified at D.C. Code, 2001 Ed. §§ 7 -301 to 7-304, as amended;

(b) The term "Disease" mean any of the disease enumerated in § 125.2;

(c) The term "Department" mean the Department of Public Health of the District of Columbia; and

(d) The term "Director" mean the Director of Public Health, or his or her designated agent.

125.4

Each case of any disease listed in § 125.2 shall be reported to the Director, on a form prescribed and furnished by the Director, by the physician, or other person responsible for the care of a patient, confidentially, in writing, after a determination has been made that a patient is suffering from any of the diseases cited in § 125.2.

125.5

Information pertaining to the medical history of a reported case, in addition to that forwarded to the Director as required by § 125.4, shall be furnished upon request of the Director.

125.6

[Repealed] D.C. Law 6-83, 32 DCR 7276 (December 13, 1985).

D.C. Mun. Regs. tit. 22, r. 22-B125

Commissioners' Order 61-1117 (June 20, 1961), 8 DCRR §§ 8 -5:201 to 8-5:205 (1965); as amended by the Preventive Health Services Amendments Act of 1985 § 7, D.C. Law 6-83, 32 DCR 7276 (December 13, 1985)